Celltrion Healthcare Australia

Company snapshot

Celltrion is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Access to advanced yet costly therapeutics is often a challenge to patients and healthcare providers. In particular, Biologics have become an increasingly important but also expensive part of the g

• 10 active pipeline program(s) linked via ClinicalTrials.gov.
• 10 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Celltrion Healthcare Australia. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Celltrion Healthcare Australia.

1. Jun 8, 2026 Clinical update

   CT-P55 3.1 — Phase 3

2. Jun 8, 2026 Clinical update

   CT-P51 3.1 — Phase 3

3. Jun 8, 2026 Clinical update

   CT-P51 1.1 — Phase 1

4. Jun 8, 2026 Clinical update

   CT-P44 3.1 — Phase 3

5. Jun 8, 2026 Clinical update

   CT-P13 3.11 — Phase 3

View all clinical trial activity →

• What is Celltrion Healthcare Australia?

  Celltrion Healthcare Australia is a pharma organization headquartered in Sydney, AU. Primary therapeutic focus areas include Rheumatoid arthritis, Completely Resected Stage IIB, IIC, and III Melanoma, Previously Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer, HER2-p

• Is Celltrion Healthcare Australia publicly traded?

  Celltrion Healthcare Australia appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Celltrion Healthcare Australia develop or market?

  We link 44 drug profile(s) where Celltrion Healthcare Australia is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/celltrion-healthcare-hungary-kft#company-drugs.

• What are the latest developments for Celltrion Healthcare Australia?

  In the last 12 months our linked public records show 10 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Celltrion Healthcare Australia focus on?

  Celltrion Healthcare Australia focuses on Rheumatoid arthritis, Completely Resected Stage IIB, IIC, and III Melanoma, Previously Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer based on our analysis of their pipeline programs and drug development activities.